Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials - PubMed (original) (raw)
- PMID: 1895215
Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials
P J Bugelski et al. J Acquir Immune Defic Syndr (1988). 1991.
No abstract available
Similar articles
- [Treatment of HIV infection: perspectives].
Monsuez JJ. Monsuez JJ. Pathol Biol (Paris). 1992 Jun;40(6):609-20. Pathol Biol (Paris). 1992. PMID: 1383913 French. No abstract available. - Soluble CD4: another therapeutic option in HIV infection.
[No authors listed] [No authors listed] Lancet. 1990 May 12;335(8698):1128-30. Lancet. 1990. PMID: 1971867 Review. No abstract available. - Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR Jr, Leary J, Bugelski PJ. Hart TK, et al. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93. doi: 10.1073/pnas.88.6.2189. Proc Natl Acad Sci U S A. 1991. PMID: 2006155 Free PMC article. - Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
Lynch G, Low L, Li S, Sloane A, Adams S, Parish C, Kemp B, Cunningham AL. Lynch G, et al. J Leukoc Biol. 1994 Sep;56(3):266-72. doi: 10.1002/jlb.56.3.266. J Leukoc Biol. 1994. PMID: 7521897 - CD4-gp120 interactions.
McDougal JS, Klatzmann DR, Maddon PJ. McDougal JS, et al. Curr Opin Immunol. 1991 Aug;3(4):552-8. doi: 10.1016/0952-7915(91)90020-2. Curr Opin Immunol. 1991. PMID: 1721822 Review.
Cited by
- Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.
Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y, Schmidt SD, McKee K, Louder MK, Ledgerwood JE, Graham BS, Haynes BF, Burton DR, Wyatt RT, Mascola JR. Li Y, et al. J Virol. 2011 Sep;85(17):8954-67. doi: 10.1128/JVI.00754-11. Epub 2011 Jun 29. J Virol. 2011. PMID: 21715490 Free PMC article. - Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.
Haim H, Si Z, Madani N, Wang L, Courter JR, Princiotto A, Kassa A, DeGrace M, McGee-Estrada K, Mefford M, Gabuzda D, Smith AB 3rd, Sodroski J. Haim H, et al. PLoS Pathog. 2009 Apr;5(4):e1000360. doi: 10.1371/journal.ppat.1000360. Epub 2009 Apr 3. PLoS Pathog. 2009. PMID: 19343205 Free PMC article. - Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
Chertova E, Bess JW Jr, Crise BJ, Sowder II RC, Schaden TM, Hilburn JM, Hoxie JA, Benveniste RE, Lifson JD, Henderson LE, Arthur LO. Chertova E, et al. J Virol. 2002 Jun;76(11):5315-25. doi: 10.1128/jvi.76.11.5315-5325.2002. J Virol. 2002. PMID: 11991960 Free PMC article. - Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.
Kolchinsky P, Kiprilov E, Bartley P, Rubinstein R, Sodroski J. Kolchinsky P, et al. J Virol. 2001 Apr;75(7):3435-43. doi: 10.1128/JVI.75.7.3435-3443.2001. J Virol. 2001. PMID: 11238869 Free PMC article. - Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.
Kolchinsky P, Kiprilov E, Sodroski J. Kolchinsky P, et al. J Virol. 2001 Mar;75(5):2041-50. doi: 10.1128/JVI.75.5.2041-2050.2001. J Virol. 2001. PMID: 11160708 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials